What researchers published on Petefészekrák
43 193 papers, newest first.
Showing 200 of 43 193
EsetismertetésFamilial Ovarian Teratoma With Neural Tissue Expression and Anti-NMDAR Encephalitis.Neurology(R) neuroimmunology & neuroinflammation
Matrix Softness and Fluid Shear Force Act Through TRPV4 to Promote Ovarian Cancer Stemness.Advanced science (Weinheim, Baden-Wurttemberg, Germany)
ÁttekintésTumor-associated macrophages in ovarian, prostate, thyroid and pancreatic neuroendocrine tumors: molecular crosstalk and therapeutic perspectives.Molecular biology reports
Generation of mixed ovarian cancer and fibroblast spheroids by bioprinting.In vitro models
Cross-database thromboembolic reporting signals for ovarian cancer therapies: a focus on bevacizumab.BMC cancer
[Emphasis on the standardization of initial treatment for ovarian cancer].Zhonghua yi xue za zhi
ÁttekintésAdvances in Biomarker Discovery for Early Ovarian Cancer Diagnosis.Cells
Diagnostic Performance of Contrast-Enhanced Computed Tomography in Predicting Lymph Node Metastasis in Epithelial Ovarian Cancer: The Added Value of Combining CT with CA-125.Diagnostics (Basel, Switzerland)
Infrared Treatment Alters the Chemical Profile and In Vitro Bioactivity of Jojoba Oil: Antimicrobial, Biofilm Formation Inhibition and Ovarian Cancer Cell Responses.International journal of molecular sciences
FABP4 is associated with ROS-dependent ferroptosis inhibition and platinum resistance in ovarian cancer.Tissue & cell
ÁttekintésImmune Resistance and Anti-Tumor Immunity in the Ovarian Tumor Microenvironment.Cells
PADI2 facilitates progression and cisplatin resistance of epithelial ovarian cancer via m6A methylation.iScience
Biologic and immunologic characteristics of ovarian cancers that are associated with p53 autoantibodies.Cancer
ÁttekintésPrognostic Value of the KELIM Score Versus Conventional CA-125 Kinetics in Ovarian Cancer: A Systematic Review and Meta-Analysis.Diagnostics (Basel, Switzerland)
Comparison of Sonidegib and Vismodegib Efficiency in Drug-Sensitive and Resistant Ovarian Cancer Cell Lines-2D and 3D Model Study.International journal of molecular sciences
ÁttekintésThe Role of D-3-Phosphoglycerate Dehydrogenase (PHGDH) in Chemoresistance in Ovarian Cancer: Molecular Insights and Therapeutic Potential.International journal of molecular sciences
Multicenter Evaluation of Decentralized Homologous Recombination Deficiency Testing for Enhanced Molecular Diagnosis of Ovarian Cancer.International journal of molecular sciences
A leakage-aware and interpretable machine learning framework for ovarian cancer prediction using the PLCO screening dataset.Frontiers in oncology
Hypoxia-Associated Glycolytic-Lipogenic Reprogramming and Impaired Antigen Presentation in SPP1+ Tumor-Associated Macrophages in Ovarian Cancer.International journal of molecular sciences
Correction: Gralewska-Zając et al. Liposomal Vitamin C as a Modulator of the Efficacy of Ceralasertib Therapy in Ovarian Cancer. Int. J. Mol. Sci. 2026, 27, 2630.International journal of molecular sciences
ÁttekintésFolate Receptor Alpha (FRα/FOLR1) in Cancer: Diagnostic, Prognostic or Predictive Biomarker? A Critical Review of Its Clinical Utility.International journal of molecular sciences
Comparison of Survival Outcomes with First-Line PARP Inhibitor Maintenance According to BRCA Mutation and Homologous Recombination Deficiency Status in Advanced Ovarian Cancer: A Single-Center Retrospective Cohort Study.Cancers
ÁttekintésExtracellular Vesicle-Associated Epithelial-Mesenchymal Plasticity (EMP) as a Driver of Metastatic Evolution and Therapeutic Resistance in Ovarian Cancer.Cancers
Platelet-Derived Extracellular Vesicles for the Diagnosis of Ovarian Cancer.Cancers
"Hearing the Ovarian Cancer Whisper": A Pipeline Program Introducing Medical Students to Gynecologic Oncology, Focusing on the Diagnosis and Management of Ovarian Cancer.Medical science educator
Minimally invasive surgery improves surgical and analgesic outcomes in overweight or obese patients with borderline ovarian tumors: A retrospective cohort study.Medicine
Compartment-Resolved Profiling Identifies Shared Stromal Programs and Clarifies Molecular Subtype Origins in Ovarian Cancer.Cancer research
ÁttekintésCellular senescence in ovarian cancer: context-dependent effects on tumor immunity and therapy response.Frontiers in immunology
Risk Factor Profiles May Differ Between Younger-Onset and Late-Onset Colorectal Cancer: An Exploratory Analysis of Individual and Cumulative Risk Factors Among the Prostate, Lung, Colorectal and Ovarian Cohort.Asia-Pacific journal of clinical oncology
Multi-omics-constrained kinetic models quantify pathway rewiring and predict metabolic vulnerabilities in BRCA1-deficient ovarian cancer.Cell systems
Clinical characteristics and treatment strategies of ovarian teratomas associated with anti-N-methyl-D-aspartate receptor encephalitis based on a case series.Frontiers in neurology
Tuberculous Salpingo-Oophoritis Mimicking Ovarian Malignancy: A Case Report of a Diagnostic Dilemma.Clinical case reports
MRPL47 as a mitochondrial biomarker for early detection and therapeutic response in ovarian cancer.Molecular therapy. Oncology
Surgical opportunities for primary prevention of high-grade serous ovarian cancer: a procedure-level analysis of opportunistic salpingectomy.Journal of ovarian research
Perillaldehyde (PAE) Regulates Ovarian Cancer by Modulating HSP70 and Regulating the PI3K/AKT Signaling Pathway.Archives of biochemistry and biophysics
Vizsgálati eredményPamiparib plus surufatinib with ctDNA monitoring in platinum-resistant ovarian cancer after PARP inhibitor progression: a phase Ib/II trial (POST-PARPi).BMC medicine
AIF promotes ovarian cancer progression by competitively binding TRAP1 to stabilize MtCK1 to drive phosphocreatine synthesis.Journal of translational medicine
Fertility-sparing surgery for early-stage epithelial ovarian cancer: evolving criteria for patient selection.Japanese journal of clinical oncology
Randomizált vizsgálatFuzuloparib in combination with apatinib versus fuzuloparib alone for recurrent ovarian cancer: a randomized, open-label, phase 2 trial.Journal of ovarian research
PD-L1 expression in epithelial ovarian cancer and survival: a retrospective cohort study.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia
Racial and ethnic differences in ovarian cancer survival across SEER registry states.Gynecologic oncology
ÁttekintésThe hidden genome of high-grade serous ovarian carcinoma: repetitive DNA, extrachromosomal DNA, and complex structural variation.Frontiers in molecular biosciences
The p38α MAPK-MK2 axis drives chemotherapy-mediated nuclear actin remodeling to promote ovarian cancer progression.Proceedings of the National Academy of Sciences of the United States of America
Editorial: New horizons in the management of advanced epithelial ovarian cancer.Frontiers in medicine
Epigenetic Divergence Distinguishes Molecularly and Histologically Distinct Subtypes of Small Cell Carcinoma of the Ovary Hypercalcemic Type.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Cell-death-associated inflammatory remodeling of the SPP1/KRT5 axis in high-grade serous ovarian cancer: multi-omics, single-cell, and irradiation validation.Frontiers in cell and developmental biology
A peritoneal cancer index above 14 is associated with incomplete cytoreduction in cytoreductive surgery with HIPEC for high-grade serous ovarian cancer.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Deep learning radiomics nomogram based on enhanced CT for differentiating epithelial ovarian borderline tumors and early-stage epithelial ovarian cancers.BMC cancer
Causal effects of genetically predicted CCL25 signaling on ovarian cancer risk: A 2-sample Mendelian randomization study.Medicine
EsetismertetésManagement of an incidentally discovered pancreatic neoplasm mimicking an ovarian neoplasm during pregnancy: A case report.Medicine
MetaanalízisPoly (ADP-ribose) polymerase inhibitors (PARPi) for treating advanced epithelial ovarian cancer.The Cochrane database of systematic reviews
Hypermethylation in CpG-rich cfDNA fragments enables accurate detection of circulating tumor DNA in BRCA1- and BRCA2-associated breast and ovarian cancer.NPJ breast cancer
Selective miRNA network modulation by quinolone derivative CF5 is associated with potent anti-ovarian cancer activity.Bioscience reports
ÁttekintésBEHOLD phase 3 clinical development program of mocertatug rezetecan in ovarian and endometrial cancer.Gynecologic oncology
[Oncogenetics consultation].Annales de chirurgie plastique et esthetique
Considerations on external validation, potential data leakage, and model selection in a PET/CT-based radiomics model predicting residual disease in ovarian cancer.Journal of ovarian research
Risovalisib for PIK3CA-mutated recurrent or persistent ovarian clear cell carcinoma: a single-arm, multicentre, phase 2 trial.The Lancet. Oncology
Identification and Biological Evaluation of Fisetin as a Novel DYRK1B Inhibitor in Ovarian Cancer with Apoptotic and Ferroptotic Effects.Drug design, development and therapy
Prospective Analysis of Breastfeeding History and Ovarian Cancer Risk: Results From the Ovarian Cancer Cohort Consortium.International journal of cancer
EsetismertetésBreast metastasis from BRCA1-mutated ovarian cancer: response to parp inhibition and a potential lymphatic route.BMC women's health
ÁttekintésAdvances in the application of fluorescent probes for ovarian cancer.Journal of ovarian research
Blood-based RNA biomarker for the early detection of ovarian cancer.Nature medicine
Correction: Carboxylesterase 1 is a core metabolic vulnerability of platinum-resistant high-grade serous ovarian carcinoma.Journal of experimental & clinical cancer research : CR
A novel candidate biomarker for detecting premalignant and early ovarian cancer.Nature medicine
ÁttekintésExosomal microRNAs in apoptosis and chemoresistance of ovarian cancer: mechanisms and therapeutic implications.Medical oncology (Northwood, London, England)
Development and Validation of Machine Learning Models Incorporating TGFBIp Expression for Prognosis Prediction in Epithelial Ovarian Cancer.Cancer reports (Hoboken, N.J.)
Synergistic antitumor activity of Napabucasin and Curcumin via ROS accumulation and apoptotic cell death induction in ovarian cancer cells.Molecular biology reports
Association of Preoperative Systemic Inflammation Response Index and Neutrophil-to-Lymphocyte Ratio with Cytoreduction Outcomes in Ovarian Cancer: A Retrospective Cohort Study.International journal of women's health
RAD52 is a therapeutic vulnerability for acquired PARP inhibitor resistance in ovarian cancer.JCI insight
EsetismertetésManagement of a perforated extensive ovarian tumor with radical resection and long-term tumor-free outcome: a case report.Journal of medical case reports
Feasibility of transvaginal ultrasound with endorectal micro-enema for the detection of rectosigmoid anastomotic leakage after cytoreductive surgery for ovarian cancer: preliminary experience from an ambispective single-center study.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
UHRF1 Supports PARP1 Protein Stability and Ovarian Cancer Progression by Limiting PARP1 Polyubiquitination.Cancer science
Corrigendum to "Methods for isolation, detection and characterization of circulating tumor cells in epithelial ovarian carcinoma and summarized evidence of their association with survival outcome: a scoping review" [Crit. Rev. Oncol./Hematol. 227 (2026) 105614].Critical reviews in oncology/hematology
Megfigyeléses vizsgálatPreoperative discrimination of malignant and benign ovarian masses using cfDNA fragmentomics and serum biomarkers.Molecular biomedicine
ÁttekintésThe role of carbonic anhydrases IX and XII in hypoxia-driven tumor adaptation and chemoresistance: an underexplored frontier for novel therapeutic strategies in ovarian cancer.Cancer biology & therapy
ÁttekintésIdentification of ovarian cancer cell based on mechanical properties of regional heterogeneity of cells.Biosensors & bioelectronics
ÁttekintésExploring the molecular pathways of Noncoding RNAs in ovarian cancer: insights into treatment resistance.Journal of ovarian research
Fertility and Oncological Outcomes of Ovarian Cancer Patients Treated With Fertility Sparing Surgery.Indian journal of surgical oncology
PAQR5 links microvascular invasion, innate immune inflammatory amplification, and platinum resistance in ovarian cancer.Translational oncology
Comment on "Breast cancer prevention in patients with gBRCA-mutated ovarian cancer".Journal of cancer research and clinical oncology
EsetismertetésMultidisciplinary management of adult-type ovarian granulosa cell tumor in a patient with severe peripheral arterial disease and chronic limb-threatening ischemia: a case report.Journal of medical case reports
Practical application and exploratory prognostic assessment of the FIGO 2023 stage IA3 criteria in endometrioid endometrial cancer with concurrent ovarian tumours.International journal of clinical oncology
Beyond the surgeon's eye: towards a molecular definition of complete cytoreduction in advanced ovarian cancer.Gynecologic oncology
[Corrigendum] CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.Oncology reports
CT-Derived Body Composition Enhances Risk Prediction for Early Progression and Platinum Resistance in High-Grade Serous Ovarian Cancer.Cancer medicine
Response by Wang to "Post-PARP platinum resistance and biomarker re-evaluation in East Asian ovarian cancer cohorts".Journal of gynecologic oncology
Response by One et al. to "Post-PARP platinum resistance and biomarker re-evaluation in East Asian ovarian cancer cohorts".Journal of gynecologic oncology
ÁttekintésThe Tumor Microenvironment of Ovarian Cancer through a Spatial Topological Lens: From Immune Exclusion Mechanisms to Next-Generation Precision Interventions.Critical reviews in oncology/hematology
Progression on PARP versus prior PARP exposure: interpreting subsequent platinum sensitivity in ovarian cancer.Journal of gynecologic oncology
Correction to "Proteomic Studies That Predict Patients' Responses to High-Grade Serous Ovarian Cancer Treatments: A Systematic Review".Journal of proteome research
ÁttekintésTargeting histone methylation with ROS nanoparticles delivering PARPi prodrugs to amplify the stimulation of cGAS-STING for immunotherapy in ovarian cancer.Materials today. Bio
Combined baicalein and the neocryptolepine derivative Z2 enhance anti-ovarian cancer efficacy by inhibiting the CDK4/6-Rb signaling pathway.Toxicology and applied pharmacology
ÁttekintésImmunotherapy in Advanced Epithelial Ovarian Cancer: Successes and Frustrations.Oncology research
Hsa_Circ_0000615-Encoded 250-Amino Acid Polypeptide Suppresses Epithelial Ovarian Cancer Progression via Promoting HMGB1 Nuclear Accumulation.Oncology research
Expression, association with clinicopathological features and prognostic potential of FOXR2, mTOR, HIF-1α and PKM2 in high-grade serous carcinoma of the ovary.Diagnostic pathology
ÁttekintésMetabolic Landscape and Immune Microenvironment in Ovarian Cancer: Mechanisms of Remodelling and Therapeutic Opportunities.Immunology
ÁttekintésOvarian Carcinoma: Signal Pathways and Clinical Studies.MedComm
An interpretable machine learning model integrating 54 test indicators and age: a single-center study on precise discrimination between serous ovarian cancer and ovarian cysts.BMC medical informatics and decision making
RPPH1 drives ovarian cancer cells proliferation via CDK9-c-Myc axis.Journal of ovarian research
To interpret gypenoside-L mediated PIWI/piRNA regulatory effect on cuproptosis in ovarian cancer and the mechanism based on PANDORA-seq.Journal of natural medicines
Assessment of genomic instability and homologous recombination repair in ovarian cancer using the Oncomine Comprehensive Assay Plus.Oncotarget
CRIP1 Promotes Ovarian Cancer Progression by Mediating the KRAS-USP7 Interaction and Stabilizing KRAS.Reproductive sciences (Thousand Oaks, Calif.)
Complete Surgical Resection of Rare Solitary Anterior Mediastinal Metastasis From Ovarian Clear Cell Carcinoma.Respirology case reports
Statement of Retraction: Loss of Ras GTPase-activating protein SH3 domain-binding protein 1 (G3BP1) inhibits the progression of ovarian cancer in coordination with ubiquitin-specific protease 10 (USP10).Bioengineered
Corrigendum to "Development and validation of a sensitive LC-MS/MS method for the assay of four PARP inhibitors in human plasma and its application in ovarian cancer patients" [J. Pharmaceut. Biomed. Anal. 237 (2024) 115758].Journal of pharmaceutical and biomedical analysis
Retraction notice to "389P Monocyte reprogramming in high-grade serous ovarian cancer and chemotherapy impact: A single-cell RNA sequencing study": [Annals of Oncology. Volume 35, Supplement 4, December 2024, Page S1549].Annals of oncology : official journal of the European Society for Medical Oncology
Exosomal circ_0000387 Is Associated With Ovarian Cancer Metastatic Regulation Through IGF2BP3-Related Signalling and Endothelial VWF Responses.Journal of biochemical and molecular toxicology
Image-guided photothermal therapy in ovarian cancer using a pH-sensitive ICG/TPZ nanoliposome to overcome thermoresistance.Colloids and surfaces. B, Biointerfaces
The hMOF/PCNA Axis Mitigates Cisplatin Resistance in Ovarian Cancer Cells via Modulating DNA Damage Response.Reproductive sciences (Thousand Oaks, Calif.)
Stromal APOL4 defines a cancer-associated fibroblast state that organizes a chemosensitive niche in ovarian cancer.Experimental & molecular medicine
NFE2L1 promotes cisplatin resistance by attenuating ferroptosis through SLC27A2-mediated fatty acid metabolism in ovarian cancer.Cell death and differentiation
ÁttekintésThe Role of miRNAs in Regulating Cellular Senescence: A Potential Strategy for Overcoming Drug Resistance in Ovarian Cancer.Frontiers in bioscience (Landmark edition)
Vizsgálati eredményOlaparib plus tremelimumab in women with recurrent ovarian cancer and a germline BRCA1 or BRCA2 mutation: a phase I/II study.Nature communications
Targeting oxidative phosphorylation with lixumistat overcomes PARP inhibitor resistance in ovarian cancer.Cell death & disease
Elevated human epididymis protein 4 levels in chronic kidney disease compromise the accuracy of the risk of ovarian malignancy algorithm.Experimental and therapeutic medicine
In situ hydrogel nanovaccine based on whole-cell tumor antigen efficiently activates adaptive immunity for the prevention and treatment of ovarian cancer.Acta pharmaceutica Sinica. B
Curcumin in ovarian cancer: mechanistic promise and the pharmacokinetic barrier to clinical translation.Natural product research
Repositioning of cis-flupentixol for the suppression of ovarian cancer cell migration and invasion through ERK5 inhibition.Molecular medicine (Cambridge, Mass.)
METTL3-mediated m6A modification of DNMT1 enhances ovarian cancer progression.Science advances
Economic evaluation alongside the PAOLA-1 /ENGOT-ov25 trial: cost of ovarian cancer and cost-effectiveness of olaparib plus bevacizumab first-line maintenance.Cost effectiveness and resource allocation : C/E
Chemotherapy-refractory high-grade serous ovarian carcinoma: single-cell findings, TCGA-OV transcriptomic context, and a single-case MRI-transcriptome illustration.Frontiers in genetics
ÁttekintésArtificial intelligence assisted genomic profiling of ovarian cancer liver metastases.Frontiers in genetics
Preferential toxicodynamic effects of fenbendazole in ovarian cancer and nonmalignant ovarian cell models.Drug and chemical toxicology
Calcified foraminal metastasis from ovarian low-grade serous carcinoma mimicking a nerve sheath tumor.Skeletal radiology
Application of semidefinite programming approach for detection of genomic copy number variations from peripheral blood in ovarian cancer.Frontiers in oncology
A modified ovarian-adnexal reporting and data system ultrasound for differentiating ovarian carcinoma: integration of the risk of malignancy algorithm into the American College of Radiology's O-RADS US framework.Frontiers in oncology
Patient characteristics and clinical indicators influencing oncologists' perceptions of prognosis in ovarian cancer: a discrete choice experiment.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Poly(adenosine diphosphate-ribose) polymerase-inhibitor response evaluation in recurrent epithelial ovarian cancer using circulating tumor DNA and functional homologous recombination-deficient testing.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Synergistic antitumor effects of combined pembrolizumab and anlotinib via EGFR inhibition and tumor microenvironment remodeling in high-grade serous ovarian cancer.Frontiers in oncology
Longitudinal human epididymis protein 4 kinetics in first-line treatment of advanced ovarian carcinoma: Mathematical modeling and prognostic implications.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Prognostic value of PD-L1 expression and association with HRD in high-grade serous ovarian cancer: an ancillary analysis of the PAOLA-1/ENGOT-ov25 trial (GINECO).ESMO open
Integrative Multi-Model Analysis Identifies a Core Gene Signature Associated with WEE1 Inhibitor Resistance, the Resistance-Associated Tumor Microenvironment, and Therapeutic Vulnerability in Ovarian Cancer.Current cancer drug targets
Concentration-Based Short-Course Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at Interval Cytoreductive Surgery (iCRS) for Advanced Ovarian Cancer: Final Analysis of Overall Survival in a Phase 2 Trial.Journal of surgical oncology
T2-weighted MRI-based radiomics for preoperative prediction of homologous recombination deficiency status in high-grade serous ovarian carcinoma.Abdominal radiology (New York)
EsetismertetésPrimary ovarian insular carcinoid in an infertile woman managed with fertility preservation: a case report.BMC women's health
Microfluidic lipid nanoparticles co-delivering siMOB1A and paclitaxel for ovarian cancer therapy.Journal of ovarian research
Ferroportin deficiency drives olaparib resistance in ovarian cancer via the cGAS-STING-STAT3 survival axis.Clinical and translational medicine
MetaanalízisPrognostic factors of synchronous endometrial and ovarian cancers: a systematic review and meta-analysis of cohort studies.BMC cancer
CT-based adaptation of the Vizzielli laparoscopic risk-adjusted score in advanced ovarian cancer: Agreement and inter-reader reproducibility.European journal of radiology
Fallopian tube cytology combined with p53 and PAX-8 immunocytochemistry in diagnosing ovarian carcinoma: a prospective study.BMC cancer
[Uterine tumor resembling ovarian sex cord tumor: a clinicopathological and molecular analysis of ten cases].Zhonghua bing li xue za zhi = Chinese journal of pathology
Áttekintés[Advances and hot topics in the treatment of epithelial ovarian cancer].Zhonghua yi xue za zhi
Dichotomous assessments of homologous recombination deficiency are insufficient predictive biomarkers for the PARP inhibitor treatment of ovarian cancer.Clinical and translational medicine
Near-Infrared Light-Responsive Liposomes for Modulating Switchable CAR-T Cell Therapy.International journal of nanomedicine
Thoracic recurrence after complete gross resection in advanced ovarian cancer: The clinical impact of occult subdiaphragmatic lymphatic invasion.Gynecologic oncology
Clinical outcomes of 5-day administration of topotecan combined with bevacizumab for platinum-resistant ovarian cancer: a multicenter retrospective analysis.International journal of clinical oncology
Mechanical dysfunction: ovarian cancer ascites disables NK cells by suppressing CDC42-driven force generation.Frontiers in immunology
Boosting ovarian cancer immunotherapy via discoidin domain receptor 2 blockade and CD28 x mucin 1 bispecific antibodies.BMC medicine
Targeting monocyte dysregulation in ovarian cancer: insights from single-cell genomics and Mendelian randomization.Journal of ovarian research
ÁttekintésCell death-based treatment of ovarian cancer.Cell death & disease
Surgical quality and long-term outcomes in advanced ovarian cancer: a population based registry study from Hamburg, Germany 2014-2024.Archives of gynecology and obstetrics
Cancer stem cell marker CD44 in epithelial ovarian tumors: Association with adverse prognostic features in invasive carcinomas.Indian journal of pathology & microbiology
EsetismertetésA urothelial cell carcinoma in the abdominal cavity after salpingectomy for tubo-ovarian carcinoma risk reduction in a BRCA1 pathogenic variant carrier.Gynecologic oncology reports
Ovarian sex cord-stromal tumors are part of the BAP1-tumor predisposition syndrome: evidence from human carriers and mouse models.NPJ precision oncology
SLC25A39 potentiates the RXFP1/cAMP/PKA/CREB axis to drive metabolic reprogramming and tumor progression in ovarian cancer.Cell biology and toxicology
Regulatory mechanism of M2d tumor-associated macrophage-derived exosomal apolipoprotein E on platinum resistance in ovarian cancer.Frontiers in oncology
Experimental benchmarking of in silico annotations at prostate cancer risk loci and hypothesis-generating cross-cancer prioritisation of ovarian risk variants.Genomics & informatics
Injectable and Bio-responsive Hydrogels for On-Demand Intraperitoneal Delivery of Anti-Cancer Therapeutics in Ovarian Cancer.Acta biomaterialia
Ultrasonography (IOTA-ADNEX) vs magnetic resonance imaging (ADNEX MR) for diagnosing ovarian cancer in high-risk patients: a prospective study.Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
Mechanistic ODE modelling of ovarian tumour microenvironment dynamics under hesperidin exposure.Royal Society open science
BRCA1 Mutation-Recognizing Tetrahedral Framework Nucleic Acid Nanoplatform Enables Coordinated PARP/WEE1 Inhibition and STING-Associated Antitumor Immunity in Ovarian Cancer.Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Segmentation of ovarian cancer tumors from CT images based on a two-stage neural network fusion system.Frontiers in artificial intelligence
TAMs-derived exosomal PD-L1 drives mitochondrial dysfunction and aberrant fatty acid oxidation via PGC-1α/PPARα axis to promote peritoneal metastasis in epithelial ovarian cancer.Journal of ovarian research
ESM1 drives H4K8 lactylation to promote vasculogenic mimicry and bevacizumab resistance in ovarian cancer.Cell communication and signaling : CCS
ÁttekintésPredictive Biomarker Tests for Ovarian Cancer: A Primer for Pathologists.Surgical pathology clinics
The role of laparoscopic and robotic surgery in epithelial ovarian cancer: A consensus statement of the Taiwan Association of Minimally Invasive Gynecology (TAMIG).Taiwanese journal of obstetrics & gynecology
ÁttekintésTargeting G2/M checkpoint vulnerability in homologous recombination-proficient tumors: lessons from ovarian cancer models.Cell cycle (Georgetown, Tex.)
Is the preoperative routine blood test workable to distinguish early-stage from advanced-stage ovarian cancer?Taiwanese journal of obstetrics & gynecology
Struma ovarii: Diagnostic pitfalls, management strategies, and clinical outcomes from a tertiary medical center.Taiwanese journal of obstetrics & gynecology
Optimizing treatment sequencing to the platinum-resistant ovarian cancer (PROC) patients is worthy of further identification.Taiwanese journal of obstetrics & gynecology
Beyond a single ratio: an adaptable deep learning approach to analyze the prognostic value of TSP distribution in ovarian cancer.The Journal of pathology
Expression and clinical significance of WBC, hs-CRP, and ROMA index, and tumor markers in endometriosis.BMC women's health
The Duffy-Null genotype and epithelial ovarian cancer survival in a cohort of Black women.Gynecologic oncology
Burden, Risk Factors, and Temporal Trends of Ovarian Cancer in Postmenopausal Women Aged 55 Years and Older: A Comparative Analysis in India, China, and the United States Based on the Global Burden of Disease Study 2023.International journal of women's health
ÁttekintésFunctional biomarkers complementing static BRCA/HRD testing for dynamic PARP inhibitor therapy in ovarian cancer: a narrative review.Frontiers in oncology
CD44-Targeted Antibody-Drug Conjugates Suppress Ovarian Tumor Progression and Remodels Cancer Stem Cell-Associated Molecular Programs.Advanced healthcare materials
Tissue Factor Expression Is Associated with Distinct Pattern of Immune-Cell Infiltration in the Ovarian Tumor Microenvironment.International journal of molecular sciences
Attention-based hierarchical graph autoencoder for dose-specific single-cell resistance dynamics.BMC bioinformatics
Exploratory Analysis of Selected MicroRNAs as Tissue-Based Candidate Biomarkers in Ovarian Cancer.International journal of molecular sciences
Triple-Encoding Platform for Multiplexed In Situ Profiling of Extracellular Vesicle miRNAs Enables Precision Diagnosis of Ovarian Cancer.ACS nano
Deep Learning of Position-Aligned Dynamic Cell Deformation Trajectories for Ovarian Cell Phenotyping in Hyperbolic Microchannels.Analytical chemistry
ÁttekintésImmune checkpoint inhibitors in platinum-resistant ovarian cancer: Clinical disappointments, biological lessons, and the reopening of therapeutic opportunities.Cancer treatment reviews
CEP-1347 Enhances the Sensitivity of Ovarian Clear Cell Carcinoma Cells to Navitoclax by Downregulating MCL1.International journal of molecular sciences
Radiogenomic Analysis of Contrast-Enhanced MRI for Predicting Pathogenic BRCA Variants in Ovarian Cancer.Acta medica Okayama
Heterogeneity of folate receptor alpha expression and associations with molecular biomarker in ovarian high-grade serous carcinoma: A multicenter Chinese cohort study.Gynecologic oncology
Global, Regional, and National Burden of Ovarian Cancer Among Women of Reproductive Age, 1990-2021, with Projections to 2040: A Global Burden of Disease Study 2021 Analysis.International journal of women's health
New Advances in Ovarian Cancer.Biomedicines
TP53 Y220C hotspot mutation in clinically advanced ovarian carcinoma: Frequency and genomic features.Human pathology
Distinct sFOLR1 and Cytokine Secretion Profiles Across Marker-Enriched OVCAR-3 Ovarian Cancer Cell Subpopulations: A Pilot Study.Biomolecules
ÁttekintésOvarian Cancer Nanovaccines: Recent Strategic Advances from Antigen Selection to Carrier Design.International journal of nanomedicine
ÁttekintésNeutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Biomarkers of Ovarian Cancer in Asian Populations: A Systematic Review and Meta-analysis.Oman medical journal
Immunophenotypic Features of T-Lymphocyte Distribution Across Histological and Molecular Subtypes of Serous Ovarian Neoplasms: A Retrospective Immunohistochemical Study.Biomedicines
Validation of a Highly Specific Anti-Human Folate Receptor Alpha Single-Domain Antibody for Rapid Fluorescence-Guided Surgery of Ovarian and Lung Cancer.Biomolecules
ÁttekintésDeveloping a Conceptual Framework: Integrating Tumour, Macroenvironment and Resource (TMR) as a Composite Determinant of Ovarian Cancer Outcome in Diverse Resource Settings.Cancers
ÁttekintésCelastrol and Its Derivatives in Breast, Ovarian, and Cervical Cancer: Molecular Targets, Signalling Networks, and Nanocarrier-Based Delivery.Molecules (Basel, Switzerland)
Adipocytes Protect Ovarian Cancer Cells from Ferroptosis.Biomolecules
Nelfinavir Synergizes with Cisplatin and Promotes GSDME-Associated Lytic Cell Death in Platinum-Resistant Ovarian Cancer Cells.Pharmaceuticals (Basel, Switzerland)
Stage IV Ovarian Cancer Is Not Uniformly Lethal: Two Subgroups With Stage II-Like Outcomes Identified in Large Retrospective Cohorts.Cancer medicine
DNA Methylation Patterns Between Serous Uterine and Ovarian Carcinomas Indicate Shared Markers with Fallopian Tube Epithelium and Distinctions Consistent with Histopathology.Genes
Phenotypic Landscape of Programmed Death and TIGIT/CD155/DNAM-1 Pathways in NK Cells in Ovarian Cancer.Biomedicines